| Hdfc Pharma And Healthcare Fund Datagrid | ||||||
|---|---|---|---|---|---|---|
| Category | Pharma Fund | |||||
| BMSMONEY | Rank | N/A | ||||
| Rating | N/A | |||||
| Growth Option 27-01-2026 | ||||||
| NAV | ₹16.44(R) | +0.22% | ₹16.91(D) | +0.23% | ||
| Returns | 1Y | 3Y | 5Y | 7Y | 10Y | |
| Lumpsum | Regular | 6.46% | -% | -% | -% | -% |
| Direct | 7.72% | -% | -% | -% | -% | |
| Nifty Pharma TRI | 3.06% | 21.22% | 12.59% | 14.93% | 7.47% | |
| SIP (XIRR) | Regular | -0.83% | -% | -% | -% | -% |
| Direct | 0.37% | -% | -% | -% | -% | |
| Ratio | Sharpe Ratio | Sortino Ratio | Sterling Ratio | Jensen's Alpha | Treynor Ratio | |
| Risk | STD. Dev | VaR 1Y95% | Max DD | Beta | Semi Devi. | |
| Fund AUM | As on: 30/12/2025 | 1976 Cr | ||||
No data available
NAV Date: 27-01-2026
| Scheme Name | NAV | Rupee Change | Percent Change |
|---|---|---|---|
| HDFC Pharma and Healthcare Fund - IDCW Option | 16.44 |
0.0400
|
0.2200%
|
| HDFC Pharma and Healthcare Fund - Growth Option | 16.44 |
0.0400
|
0.2200%
|
| HDFC Pharma and Healthcare Fund - IDCW Option - Direct Plan | 16.91 |
0.0400
|
0.2300%
|
| HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan | 16.91 |
0.0400
|
0.2300%
|
Review Date: 27-01-2026
Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.
Data Source: www.amfiindia.com
| KPIs* | Fund | Nifty Pharma TRI | Cat. Avg | Min | Max | Rank (In Cat.) | Performance |
|---|---|---|---|---|---|---|
| 1M Return % | -3.90 | -3.50 |
-4.63
|
-6.50 | -3.37 | 3 | 13 | Very Good |
| 3M Return % | -4.89 | -2.32 |
-7.09
|
-9.39 | -4.89 | 1 | 13 | Very Good |
| 6M Return % | -7.15 | -4.19 |
-8.20
|
-9.74 | -6.55 | 2 | 13 | Very Good |
| 1Y Return % | 6.46 | 3.06 |
0.36
|
-4.58 | 6.46 | 1 | 13 | Very Good |
| 1Y SIP Return % | -0.83 |
-7.08
|
-19.64 | -0.83 | 1 | 13 | Very Good |
| KPIs* | Fund | Nifty Pharma TRI | Cat. Avg | Min | Max | Rank (In Cat.) | Performance |
|---|---|---|---|---|---|---|
| 1M Return % | -3.82 | -3.50 | -4.54 | -6.41 | -3.26 | 3 | 13 | Very Good |
| 3M Return % | -4.62 | -2.32 | -6.79 | -9.11 | -4.62 | 1 | 13 | Very Good |
| 6M Return % | -6.60 | -4.19 | -7.61 | -9.18 | -5.91 | 2 | 13 | Very Good |
| 1Y Return % | 7.72 | 3.06 | 1.66 | -3.02 | 7.72 | 1 | 13 | Very Good |
| 1Y SIP Return % | 0.37 | -5.84 | -18.45 | 0.37 | 1 | 13 | Very Good |
Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.
| Date | Hdfc Pharma And Healthcare Fund NAV Regular Growth | Hdfc Pharma And Healthcare Fund NAV Direct Growth |
|---|---|---|
| 27-01-2026 | 16.44 | 16.906 |
| 23-01-2026 | 16.404 | 16.867 |
| 22-01-2026 | 16.613 | 17.081 |
| 21-01-2026 | 16.459 | 16.923 |
| 20-01-2026 | 16.533 | 16.998 |
| 19-01-2026 | 16.895 | 17.37 |
| 16-01-2026 | 17.042 | 17.519 |
| 14-01-2026 | 17.195 | 17.675 |
| 13-01-2026 | 17.2 | 17.68 |
| 12-01-2026 | 17.167 | 17.646 |
| 09-01-2026 | 17.308 | 17.788 |
| 08-01-2026 | 17.492 | 17.977 |
| 07-01-2026 | 17.719 | 18.21 |
| 06-01-2026 | 17.583 | 18.069 |
| 05-01-2026 | 17.375 | 17.855 |
| 02-01-2026 | 17.344 | 17.822 |
| 01-01-2026 | 17.18 | 17.653 |
| 31-12-2025 | 17.23 | 17.704 |
| 30-12-2025 | 17.048 | 17.516 |
| 29-12-2025 | 17.108 | 17.577 |
| Fund Launch Date: 04/Oct/2023 |
| Fund Category: Pharma Fund |
| Investment Objective: To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. |
| Fund Description: An open-ended equity scheme investing in Pharma and healthcare companies |
| Fund Benchmark: BSE Healthcare Index |
Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.